Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background High-risk human papillomavirus (HR-HPV) is the leading cause of cervical cancer. Screening is one of the main cornerstones of cervical cancer prevention. Self-sampling for HR-HPV is introduced to improve patient involvement in the screening program. The study aimed to understand the hesitancy and barriers to self-sampling among high-risk women who are at risk of developing cervical cancer. Methods This qualitative study employed semi-structured telephone interviews to explore the factors behind the refusal of HR-HPV self-sampling among twelve purposefully selected women (aged 25–49) with abnormal Pap smears recruited from a colposcopy clinic within a major urban university hospital in Riga, Latvia. The interviews, conducted between June and September 2022, were transcribed verbatim and subjected to inductive content analysis. Results Results yielded four major inductively constructed categories: (1) ‘Confusion, anxiety, and other inconveniences’ describes the main aspects of patient situational anxiety, fears, and confusion during the visit to a healthcare facility that resulted in the refusal to take the HR-HPV self-sampling; (2) ‘Health literacy challenges’ highlights patients' lack of knowledge and understanding of cervical cancer causation and screening role in the early detection of cervical cancer; (3) ‘Doctor does and knows the best’ explores patients' doubts and fears about the accuracy and comparability of HR-HPV self-sampling with conventional screening methods; (4) ‘Circumstances that can promote taking the HR-HPV self-sampling’ illuminates the circumstances that can encourage women to take the HR-HPV self-sampling. Conclusions A complex interplay of contextual factors contributed to the hesitancy of HR-HPV self-sampling in the group of women at high risk for cervical cancer, highlighting that women's decision-making regarding this procedure goes beyond its purely clinical aspects.
Background High-risk human papillomavirus (HR-HPV) is the leading cause of cervical cancer. Screening is one of the main cornerstones of cervical cancer prevention. Self-sampling for HR-HPV is introduced to improve patient involvement in the screening program. The study aimed to understand the hesitancy and barriers to self-sampling among high-risk women who are at risk of developing cervical cancer. Methods This qualitative study employed semi-structured telephone interviews to explore the factors behind the refusal of HR-HPV self-sampling among twelve purposefully selected women (aged 25–49) with abnormal Pap smears recruited from a colposcopy clinic within a major urban university hospital in Riga, Latvia. The interviews, conducted between June and September 2022, were transcribed verbatim and subjected to inductive content analysis. Results Results yielded four major inductively constructed categories: (1) ‘Confusion, anxiety, and other inconveniences’ describes the main aspects of patient situational anxiety, fears, and confusion during the visit to a healthcare facility that resulted in the refusal to take the HR-HPV self-sampling; (2) ‘Health literacy challenges’ highlights patients' lack of knowledge and understanding of cervical cancer causation and screening role in the early detection of cervical cancer; (3) ‘Doctor does and knows the best’ explores patients' doubts and fears about the accuracy and comparability of HR-HPV self-sampling with conventional screening methods; (4) ‘Circumstances that can promote taking the HR-HPV self-sampling’ illuminates the circumstances that can encourage women to take the HR-HPV self-sampling. Conclusions A complex interplay of contextual factors contributed to the hesitancy of HR-HPV self-sampling in the group of women at high risk for cervical cancer, highlighting that women's decision-making regarding this procedure goes beyond its purely clinical aspects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.